PFF

3 Pharma Stocks Just Running in Place

By Lawrence Meyers, InvestorPlace Contributor
Gobs of free cash flow doesn't mean a company is worth buying. Some companies, especially pharmaceuticals, just use cash to run in place.

Your Core Portfolio: Income Securities

By Lawrence Meyers, InvestorPlace Contributor
Preferred stocks should take the place of bonds, but be ready to reallocate in a moment's notice when QE ends.

Hunting High Yield? Watch the Correction in Preferred ETFs

By David Fabian, FMD Capital Management
High-yielding preferred-stock ETFs have been pummeled amid higher interest rates, opening the doors to a buying opportunity. But don't stick your foot in yet.

Starved for High Yield? Wait a Little Longer

By Daniel Putnam, InvestorPlace Contributor
Higher-yielding areas of both the bond and equity markets have rallied hard off of their June 24 low. How long can the move in high yield continue?

3 Great Income ETFs to Buy During This Correction

By Michael Fabian, FMD Capital Management
Taking the time to hunt out bargain-priced income opportunities will have a profound impact on how you inevitably emerge from the correction.
Load More